Dr. Dhrubojyoti Mukherjee

Areas of specialization: Pharmaceutics

Experience:15 years of academic and research experience

Interest areas: Nanobiomaterials for regenerative medicine, scaffolds and composite materials, targeted drug delivery.

Research Grants

Insulin-loaded hyaluronic acid nanoparticle functionalized sodium alginate/PEG/gelatin scaffold for regeneration of bone in jaw bone defects, Indian Council of Medical Research (ICMR) Adhoc Project program, 2023 (Ongoing, Amount funded-27 Lacs)

Patents granted

• Thiolated Scaffold Based 5-Fluorouracil Loaded Nanoparticles, Indian Patent number 353786, Date of filing: 27/12/2017, Date of grant: 16/12/2020.
• Controlled Release of Bisphosphonate Loaded Mucoadhesive Delivery System for Osteoporosis, Indian Patent number: 409090, Date of filing: 23/12/2015, Date of grant: 17/10/2022.
• Compression Coated Muco-adhesive Pamidronate Disodium Buccal Compacts for Improving Bone Microarchitecture, Indian Patent number: 409662, Date of filing: 27/12/2017, Date of grant: 21/10/2022.
• Nanocomposite Functionalized Polymeric Scaffold for Skin Tissue,Indian Patent number 429773, Date of filing: 27/12/2019, Date of grant: 24/04/2023.

• A Nanohybrid Formulation Reinforced with Hydroxyapatite for Development of Bone Microarchitecture, Indian Patent number 556483, Date of filing: 24/01/2022, Date of grant: 18/12/2024.

Patents filed

• "Thiolated Sodium Alginate/PEG/HAp Nanohybrid for Improvement of Bone Microarchitecture”, Indian patent Application: 202241003992,2022. (Current Status: Filed)
• "Nanomaterial containing Ginsenoside Rg1 for management of Autism”, Indian patent Application: 202241003993, 2022. (Current Status: Filed)
• "Enhanced Brain Permeation of Thiolated Chitosan-Centella Hybrid Nanocomposite”, Indian Patent Application: 202041055907, 2020. (Current Status: Published)

Edited Book:

Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs,Bentham Science Publishers, February 2025.

• Current status of FDA-approved marketed nano drug products: regulatory considerations, Multifunctional Nanocarriers (Micro & nano Technologies Series, Elsevier), (2022) 501-521. https://doi.org/10.1016/B978-0-323-85041-4.00004-4
• Advanced Drug Delivery Systems in Hepatocellular Carcinoma, Advanced Drug DeliverySystems in Management of Cancer (Elsevier),(2021) 225-234. https://doi.org/10.1016/B978-0-323-85503-7.00023-7
• Nanocomposite hybrid polymeric scaffold for skin tissue engineering, Conference on drug design and discovery technologies (Royal Society of Chemistry), (2019). https://doi.org/10.1039/9781839160783-00195
• A novel nano-enabled nasal phytoformulation-a potential brain targeting strategy for neurodegenerative disorders, Conference on drug design and discovery technologies (Royal Society of Chemistry), (2019). https://doi.org/10.1039/9781839160783-00178
• Evaluation of cardiomyocyte targeted novel nano-formulation of pirfenidone on doxorubicin-induced heart failure in rats”, Conference on drug design and discovery technologies (Royal Society of Chemistry), (2019). https://doi.org/10.1039/9781839160783-00212
• Biomaterials for Bone Tumor: Present and Future Trends in Control and Treatment Strategy, Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs, Bentham Science Publishers, (February 2025), 176-193, https://doi.org/10.2174/97898153059061250101

Number of Publications: 20

Recent Publications:

1. Komal Sindhi, Ravindra Babu Pingili, Vishal Beldar, Sankha Bhattacharya, Jiyaur Rahaman, Dhrubojyoti Mukherjee^*. The role of biomaterials-based scaffolds in advancing skin tissue construct, Journal of Tissue Viability. (Elsevier). (January 2025). https://doi.org/10.1016/j.jtv.2025.100858 (Impact Factor- 2.4, Q2)

2. Jiyaur Rahamanand Dhrubojyoti Mukherjee^*. Insulin for oral bone tissue engineering: a review on innovations in targeted insulin-loaded nanocarrier scaffold, Journal of Drug Targeting. (Taylor & Francis),(January 2025). https://doi.org/10.1080/1061186X.2024.2445737(Impact Factor- 4.3, Q1)

3. Sankha Bhattacharya, Shashikant Bagade, Preeti Chidambar Sangave, Devendra Kumar, Imran Shaik, Dhrubojyoti Mukherjee. Comparative study of pH-responsive and aggregation stability of bosutinib-loaded nano gels comprising gelatin methacryloyl, carboxymethyl dextran, and hyaluronic acid for controlled drug delivery in colorectal cancer: an extensive in vitro investigation, Biomacromolecules. (ACS publications). (November 2024). https://doi.org/10.1021/acs.biomac.4c01209 (Impact Factor- 5.5, Q1)

4. Sahana Hulikal, Banala Venkatesh Teja, Dhrubojyoti Mukherjee^*. Thiolated eudragit/β-cyclodextrin/Centella Asiatica nanomaterial for bone tissue engineering construct, Journal of Drug Delivery Science and Technology. (Elsevier). (September 2024). https://doi.org/10.1016/j.jddst.2024.105889 (Impact Factor- 4.5, Q1)

5. Varsha Rudraardhya, Banala Venkatesh Teja, Dhrubojyoti Mukherjee^*. Hydroxypropyl Methylcellulose/sodium alginate/hydroxyapatite nano biomaterial enriched with zinc to promote bone tissue augmentation, Journal of Molecular Structure. (Elsevier). (April 2024). https://doi.org/10.1016/j.molstruc.2024.138282 (Impact Factor- 3.8, Q2)

6. Shvetank Bhatt, Kuttiappan Anitha, Dinesh Kumar Chellappan, Dhrubojyoti Mukherjee, Satish Shilpi, Ashish Suttee, Gaurav Gupta, Thakur Gurjeet Singh, Kamal Dua, Targeting inflammatory signalling in obsessive compulsive disorder: a promising approach, Metabolic Brain Disease (Springer). (November 2023). https://doi.org/10.1007/s11011-023-01314-3 (Impact Factor- 3.6, Q2)

Professional memberships: Association of Pharmaceutical Teachers of India

Other achievements/ Trainings: Attended workshop and training on nanofabrication techniques at CeNSE (Center for Nano Science and Engineering), IISc, Bangalore.

https://publons.com/researcher/1281285/dhrubojyoti-mukherjee/

https://orcid.org/0000-0003-3011-5733

Official email ID: dhrubojyoti.mukherjee@nmims.edu

Official Phone No. 91-02563 286545-51 (Extn: 131118)